BLLN Key Statistics, Chart & Performance
The current stock price of BLLN is 97.96 USD. In the past month the price decreased by -0.06%.
BLLN Latest News, Press Relases and Analysis
BLLN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.68 | 101.59B | ||
| CI | THE CIGNA GROUP | 9.32 | 70.77B | ||
| LH | LABCORP HOLDINGS INC | 16.74 | 21.96B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 118.67 | 21.83B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.62 | 20.22B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.20B | ||
| HIMS | HIMS & HERS HEALTH INC | 68.85 | 8.46B | ||
| DVA | DAVITA INC | 13.2 | 8.60B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 35.4 | 6.51B | ||
| CHE | CHEMED CORP | 19.7 | 6.14B | ||
| RDNT | RADNET INC | 204.58 | 6.00B | ||
| OPCH | OPTION CARE HEALTH INC | 22.51 | 5.32B |
Related stock screener links
About BLLN
Company Profile
BillionToOne Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Menlo Park, California. The company went IPO on 2025-11-06. BillionToOne Inc is a United States-based precision diagnostics company. The firm provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and detect risk for common and severe genetic diseases. The Company’s product UNITY, is a noninvasive prenatal screening that tests fetal cell-free DNA for cystic fibrosis (CF) and spinal muscular atrophy (SMA) through a single sample of the mother's blood.
Company Info
BILLIONTOONE INC CL A
1035 O'brien Drive
Menlo Park CALIFORNIA US
Employees: 0
Phone: 16504602552
BILLIONTOONE INC CL A / BLLN FAQ
What does BILLIONTOONE INC CL A do?
BillionToOne Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Menlo Park, California. The company went IPO on 2025-11-06. BillionToOne Inc is a United States-based precision diagnostics company. The firm provides Quantitative Counting Template (QCT) molecular counter platform, is the only technology platform that can count deoxyribonucleic acid (DNA) molecules to the single-count level and detect risk for common and severe genetic diseases. The Company’s product UNITY, is a noninvasive prenatal screening that tests fetal cell-free DNA for cystic fibrosis (CF) and spinal muscular atrophy (SMA) through a single sample of the mother's blood.
What is the stock price of BILLIONTOONE INC CL A today?
The current stock price of BLLN is 97.96 USD. The price decreased by -5.54% in the last trading session.
What is the dividend status of BILLIONTOONE INC CL A?
BLLN does not pay a dividend.
How is the ChartMill rating for BILLIONTOONE INC CL A?
BLLN has a ChartMill Technical rating of 3 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
Where is BILLIONTOONE INC CL A (BLLN) stock traded?
BLLN stock is listed on the Nasdaq exchange.
BLLN Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to BLLN.
BLLN Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |